Active ingredientAcamprosateCat. No. P-A009-001CAS 77337-76-9Family · Pharmaceutical analytical standards
Acamprosate
A medicine that helps maintain abstinence in people with alcohol dependence, approved in Europe in 1989 and in the United States in 2004; it acts indirectly on the glutamate and GABA systems, through a mechanism not yet fully understood. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Chemically it is calcium acetylhomotaurinate; it has also been studied in fragile X syndrome, for which it received orphan drug designation in the United States in 2013 and in Europe in 2014.
Go to the active ingredient →Active ingredientAcamprosateCat. No. P-A009-001CAS 77337-76-9
Pharmacopoeial impurityAcamprosate EP Impurity ACat. No. P-A009-002CAS 3687-18-1
Pharmacopoeial impurityAcamprosate EP Impurity B Potassium SaltCat. No. P-A009-004
Isotopically labelledAcamprosate-d3 CalciumCat. No. P-A009-006CAS 1225580-94-8
ImpurityAcamprosate Impurity 1 Calcium SaltCat. No. P-A009-008CAS 233591-26-9
ImpurityN-(3-Sulfopropyl) GlycineCat. No. P-A009-009CAS 77164-05-7
Active ingredientAcamprosate CalciumCat. No. P-A009-010CAS 77337-73-6No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceAcamprosate calcium CRSEDQM code Y0002199Family AcamprosateImpurityAcamprosate impurity A CRSEDQM code Y0000116Family AcamprosateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.